Short-Course Apalutamide to Reduce Active Surveillance Attrition in Prostate Cancer
MedPage Today,
Oncology/Hematology > Prostate Cancer Editorialists question whether any intervention violates principles of surveillance by…
Oncology/Hematology > Prostate Cancer Editorialists question whether any intervention violates principles of surveillance by…
In a recently published report in JAMA Oncology, Shore et al evaluated the addition of enzalutamide to the current standard of…
Fewer than 10 percent of the 100,000 men each year who get…